BiologicPatentWatch - Patent information for biologics and biosimilars

Biotechnology Industry Intelligence

Instant access to deep knowledge on biologic drugs

Start your free trial now


Preview the databaseSee plans and pricing

Tradename: TNKASE

Summary for Tradename: TNKASE

Patents:14
Applicants:1
BLAs:1
Suppliers: see list1
drug
patent expirations by year for
 TNKASE

Clinical Trials for: TNKASE

A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
Status: Completed Condition: Dysfunctional Central Venous Access Catheters

Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)
Status: Completed Condition: Myocardial Infarction

A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
Status: Completed Condition: Dysfunctional Central Venous Access Catheters

TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
Status: Recruiting Condition: Ischemic Stroke

Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction
Status: Completed Condition: Myocardial Infarction

A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters
Status: Completed Condition: Dysfunctional Hemodialysis Catheters

A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
Status: Completed Condition: Dysfunctional Hemodialysis Catheters

Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
Status: Not yet recruiting Condition: Ischemic Stroke

Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction
Status: Completed Condition: Myocardial Infarction

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)
Status: Recruiting Condition: Stroke

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Ingredient Dosage Form BLA Approval Date Patent No. Estimated Patent Expiration Status Orphan
Genentech
TNKASE
tenecteplase
VIAL103909Jun 02, 20008,236,782<disabled in preview>Active Rx
Genentech
TNKASE
tenecteplase
VIAL103909Jun 02, 20007,803,352<disabled in preview>Active Rx
Genentech
TNKASE
tenecteplase
VIAL103909Jun 02, 20008,277,830<disabled in preview>Active Rx
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. Information presented here is collected from company reports and from independent sources, and does not indicate endorsement from any company presented. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is complete or error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow BiologicPatentWatch on Twitter Connect with BiologicPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2012-2014 thinkBiotech LLC.

`abc
if (!isset($noaddthis)) echo <<< EOF EOF;